Trial reportNeuromodulation : journal of the International Neuromodulation Society2014
Predictors of implantable pulse generator placement after sacral neuromodulation: who does better?
Trial report in Neuromodulation : journal of the International Neuromodulation Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictive Factors in Sacral Neuromodulation: A Systematic Review.Urologia internationalis · 2022Pooled it
- Factors Contributing to Sacral Neuromodulation Revision: A Single-Center Study.International urogynecology journal · 2026Article
- Device-Related Reoperations 8 Years Following Sacral Neuromodulation Implantation in Older Women.International urogynecology journal · 2024Article
- Outcomes of sequential third-line therapies in patients with refractory overactive bladder.International journal of urology : official journal of the Japanese Urological Association · 2024Article
- Evaluation and management of urinary incontinence in nursing home residents: unique considerations for an at-risk population.Gynecology and pelvic medicine · 2024Review
- Sacral neuromodulation for symptomatic chronic urinary retention in females: do age and comorbidities make a difference?International urogynecology journal · 2021Article
- Sacral neuromodulation for overactive bladder in women: do age and comorbidities make a difference?International urogynecology journal · 2021Article
- Evaluation of progression from first to second stage sacral neuromodulation and unplanned device removal.Turkish journal of urology · 2021Article
- Does age alone negatively predict the outcome of sacral neuromodulation? A single-centre retrospective observational study.BMC urology · 2020Observational
- Does sex matter? A matched pairs analysis of neuromodulation outcomes in women and men.International urology and nephrology · 2018Article
- Outcomes of Sacral Neuromodulation in a Privately Insured Population.Neuromodulation : journal of the International Neuromodulation Society · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesNumerous studies have documented a relationship between provider variables, including surgeon volume and specialty, and outcomes for surgical procedures. In this study we analyzed claims data from a Medicare database to analyze outcomes of sacral neuromodulation (SNM) with respect to both provider and patient factors. MATERIALS AND
methodsA 5% random sample of Medicare beneficiaries from 1997 to 2007 was the data source. Data retrieved included demographic information, ICD-9 diagnosis codes, and CPT procedure codes. Multivariate analysis was performed to identify predictors of progression to implantable pulse generator (IPG) implantation.
resultsAfter stage I testing, urologists were more likely than gynecologists to proceed to IPG placement (Center for Medicare and Medicaid Services: 49% vs. 43%, p < 0.0001). After percutaneous testing, gynecologists were more likely than urologists to proceed to battery placement (63% vs.44%, p = 0.005). Among the patient variables analyzed, women were more likely than men to progress to battery placement. Patients treated by high-volume providers had higher rates of IPG placement after formal stage I trials (71% vs. 33%, p < 0.0001).
conclusionsThe rate of IPG implantation after SNM was greater among high-volume providers. Women had better outcomes than men. Further research may better define the relationship between outcomes of sacral neuromodulation and specific etiology of voiding dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.